Rift Valley fever (RVF) virus is an arbovirus in the Bunyaviridae family that, from phylogenetic analysis, appears to have first emerged in the mid-19th century and was only identified at the begininning of the 1930s in the Rift Valley region of Kenya. Despite being an arbovirus with a relatively simple but temporally and geographically stable genome, this zoonotic virus has already demonstrated a real capacity for emerging in new territories, as exemplified by the outbreaks in Egypt (1977), Western Africa (1988) and the Arabian Peninsula (2000), or for re-emerging after long periods of silence as observed very recently in Kenya and South Africa. The presence of competent vectors in countries previously free of RVF, the high viral titres in viraemic animals and the global changes in climate, travel and trade all contribute to make this virus a threat that must not be neglected as the consequences of RVF are dramatic, both for human and animal health. In this review, we present the latest advances in RVF virus research. In spite of this renewed interest, aspects of the epidemiology of RVF virus are still not fully understood and safe, effective vaccines are still not freely available for protecting humans and livestock against the dramatic consequences of this virus.
Rift Valley fever virus (RVFV), a phlebovirus of the family Bunyaviridae, is a major public health threat in Egypt and sub-Saharan Africa. The viral and host cellular factors that contribute to RVFV virulence and pathogenicity are still poorly understood. All pathogenic RVFV strains direct the synthesis of a nonstructural phosphoprotein (NSs) that is encoded by the smallest (S) segment of the tripartite genome and has an undefined accessory function. In this report, we show that MP12 and clone 13, two attenuated RVFV strains with mutations in the NSs gene, were highly virulent in IFNAR ؊/؊ mice lacking the alpha/beta interferon (IFN-␣/) receptor but remained attenuated in IFN-␥ receptor-deficient mice. Both attenuated strains proved to be excellent inducers of early IFN-␣/ production. In contrast, the virulent strain ZH548 failed to induce detectable amounts of IFN-␣/ and replicated extensively in both IFN-competent and IFN-deficient mice. Clone 13 has a defective NSs gene with a large in-frame deletion. This defect in the NSs gene results in expression of a truncated protein which is rapidly degraded. To investigate whether the presence of the wild-type NSs gene correlated with inhibition of IFN-␣/ production, we infected susceptible IFNAR ؊/؊ mice with S gene reassortant viruses. When the S segment of ZH548 was replaced by that of clone 13, the resulting reassortants became strong IFN inducers. When the defective S segment of clone 13 was exchanged with the wild-type S segment of ZH548, the reassortant virus lost the capacity to stimulate IFN-␣/ production. These results demonstrate that the ability of RVFV to inhibit IFN-␣/ production correlates with viral virulence and suggest that the accessory protein NSs is an IFN antagonist.Alpha/beta interferons (IFNs-␣/) are key components of the innate immune mechanisms that protect the host against invading viruses (23,31,42). The extraordinary power of the IFN system has prompted many viruses to adopt strategies that inhibit IFN production or action (for a review, see reference 13). We therefore considered the possibility that virulent strains of Rift Valley fever virus (RVFV) differ from attenuated strains in their capacity to actively antagonize the IFN response of the host. RVFV is a mosquito-borne virus which belongs to the Bunyaviridae family (Phlebovirus genus). Periodically, the virus causes epidemics and epizootics in subSaharan countries of Africa and in Egypt. In humans, infection leads to a wide spectrum of clinical symptoms that range from a benign fever to severe encephalitis, retinitis, and fatal hepatitis with hemorrhagic fever (27). Among animals, sheep and goats are severely affected.Like all members of the family, RVFV possesses a singlestranded segmented RNA genome composed of a large (L), a medium (M), and a small (S) segment (for reviews, see references 9, 11, and 40). The L and M segments are of negative polarity. The L segment codes for the RNA-dependent RNA polymerase. The M segment codes for a polyprotein which is the precursor to the...
Rift Valley fever virus (RVFV) is an important cause of epizootics and epidemics in
During natural transmission, bunyaviruses are introduced into the skin through arthropod bites, and dermal dendritic cells (DCs) are the first to encounter incoming viruses. DC-SIGN is a C-type lectin highly expressed on the surface of dermal DCs. We found that several arthropod-borne phleboviruses (Bunyaviridae), including Rift Valley fever and Uukuniemi viruses, exploit DC-SIGN to infect DCs and other DC-SIGN-expressing cells. DC-SIGN binds the virus directly via interactions with high-mannose N-glycans on the viral glycoproteins and is required for virus internalization and infection. In live cells, virus-induced clustering of cell surface DC-SIGN could be visualized. An endocytosis-defective mutant of DC-SIGN was unable to mediate virus uptake, indicating that DC-SIGN is an authentic receptor required for both attachment and endocytosis. After internalization, viruses separated from DC-SIGN and underwent trafficking to late endosomes. Our study provides real-time visualization of virus-receptor interactions on the cell surface and establishes DC-SIGN as a phlebovirus entry receptor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.